《Regenerative Medicine》雜志的最新年發文量為51篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在細胞與組織工程領域的學術影響力。
該刊聚焦于醫學-細胞與組織工程領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 較慢,6-12周 。
Regenerative Medicine 雜志發文統計
文章名稱引用次數
- Adipose-derived mesenchymal stem cell therapy in the treatment of knee osteoarthritis: a randomized controlled trial35
- Quality control guidelines for clinical-grade human induced pluripotent stem cell lines20
- Human adipose-derived mesenchymal stem cells for osteoarthritis: a pilot study with long-term follow-up and repeated injections18
- Extracellular vesicles derived from mesenchymal cells: perspective treatment for cutaneous wound healing in pediatrics11
- Channels in a porous scaffold: a new player for vascularization9
- First decade of clinical trials and published studies with mesenchymal stromal cells from umbilical cord tissue9
- Nomenclature and heterogeneity: consequences for the use of mesenchymal stem cells in regenerative medicine9
- Exploration of 2-deoxy-D-ribose and 17 beta-Estradiol as alternatives to exogenous VEGF to promote angiogenesis in tissue-engineered constructs8
- Advances in perinatal stem cells research: a precious cell source for clinical applications8
- A contemporary view of platelet-rich plasma therapies: moving toward refined clinical protocols and precise indications8
國家/地區發文量
- USA87
- England59
- CHINA MAINLAND35
- Slovenia14
- Australia13
- Canada12
- Iran11
- Brazil10
- Italy10
- Japan8
